Bionano Genomics, Inc. (BNGO) Return on equity 2018–2025
Bionano Genomics, Inc. (BNGO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-59.4%FY2025 · since FY2018: -182.5% → -59.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.4% | +257.2 pp |
| FY2024 | -316.7% | -74.9 pp |
| FY2023 | -241.8% | -188.6 pp |
| FY2022 | -53.2% | -31.7 pp |
| FY2021 | -21.5% | +95.7 pp |
| FY2020 | -117.2% | +708.0 pp |
| FY2019 | -825.2% | -642.8 pp |
| FY2018 | -182.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Gross marginBNGO Operating incomeBNGO Operating marginBNGO Operating cash flowBNGO Free cash flowBNGO Capital expendituresBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →